GlassScriptPhysician profile
Gerald T Russell
NPI 1043200603
$3,214.70
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,588 · 2020: $594 · 2021: $32.82.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $1,512.50 | 2019 | |
| Pfizer INC. | $197.70 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $188.73 | 2019-2021 | |
| Novo Nordisk INC | $158.89 | 2019-2020 | |
| Amgen INC. | $147.98 | 2019-2020 | |
| Allergan, INC. | $115.06 | 2019-2020 | |
| Glaxosmithkline, LLC. | $112.84 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $98.01 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.07 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $87.79 | 2019-2020 | |
| Lilly USA, LLC | $83.80 | 2019-2020 | |
| Amarin Pharma, INC. | $80.70 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $76.76 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.64 | 2019-2020 | |
| Astellas Pharma US INC | $58.01 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $21.14 | 2020 | |
| Esperion Therapeutics, INC. | $15.98 | 2021 | |
| Horizon Therapeutics Plc | $15.13 | 2019 | |
| Shire North American Group INC | $13.65 | 2019 | |
| Zyla Life Sciences, INC. | $13.46 | 2019 | |
| Daiichi Sankyo INC. | $13.26 | 2019 | |
| Antares Pharma, INC. | $13.23 | 2020 | |
| Endo Pharmaceuticals INC. | $12.42 | 2019 | |
| Medtronic Vascular, INC. | $12.14 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.